THIS APP-BOOK includes unique functions such as:
• A powerful search
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• High resolution pictures
• Notes and picture notes
About this title
Clinics Collections: Obesity draws from Elsevier’s robust Clinics Review Articles database to provide multidisciplinary teams, including general practitioners, endocrinologists, pediatricians, gastroenterologists, nurses, and other healthcare professionals, with practical clinical advice and insights on this highly prevalent disease and its comorbidities.
Clinics Collections: Obesity guides readers on how to apply current primary research findings on obesity to everyday practice to help overcome challenges and complications, keep up with new and improved treatment methods, and improve patient outcomes.
Areas of focus include obesity and secondary disorders, pediatric obesity, metabolic issues, dietary approaches, surgical options, and special considerations.
Each article begins with keywords and key points for immediate access to the most critical information.
Articles are presented in an easy-to-digest and concisely worded format.
Elsevier Clinics Collections provide concise reviews of today’s most prevalent conditions and significant medical developments. OtherClinics Collections titles available include Type II Diabetes Mellitus, Asthma, and Pain Management.
Authors: Joel J. Heidelbaugh
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
- $2.99 USD
Testosterone Supplementation Improves Carbohydrate and Lipid Metabolism in Some Older Men with Abdominal Obesity.
The effects of testosterone supplementation on carbohydrate and lipid metabolism in obese older men are uncertain.
Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome.
Metabolic and hormonal modifications after long-term testosterone (T) treatment have never been investigated.
Objective: Epicardial adipose tissue (EAT), the visceral fat depot of the heart, is a modifiable cardiovascular risk factor and emerging therapeutic target. Liraglutide, an analog of glucagon-like peptide-1, is indicated ...
Objective: To review the efficacy and safety of liraglutide 3.0 mg for weight loss.
Obesity has significant impact on asthma incidence and manifestations.
The National Institute for Health and Care Excellence (NICE) has published draft guidelines rejecting Mysimba/Contrave (bupropion and naltrexone) from Orexigen...
FDA issues warning relating to ReShape and Obera balloon systems that are associated with overinflation and acute pancreatitis.-ReShape Medical and Apollo Endo-Surgery.
The FDA has recently received multiple reports for two different types of adverse events associated with fluid-filled intragastric balloons used...
Phase III results from VBLOC DM2 Study of vBloc neurometabolic therapy in obese patients with type 2 diabetes published- EnteroMedics
EnteroMedics announced the publication of three-year data from the Company's VBLOC DM2 Study of vBloc Neurometabolic Therapy in obese patients...
Myalept (metreleptin) filed with EMA for leptin deficiency in patients with congenital or acquired generalized lipodystrophy- Novelion Therapeutics
Novelion Therapeutics announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Myalept (metreleptin) as...
Arena Pharmaceuticals, Inc. announced that it has amended its Belviq (lorcaserin HCl) marketing and supply agreement with Eisai Co., Ltd....
This is a 52 week, single center, open-labeled, randomized controlled trial.
A total of 150 subjects with obesity, who are free of types 1 and 2 diabetes, as well as contraindications to weight loss...
The purpose of the study is to determine the effect of setmelanotide (RM-493) on weight and other factors in patients with pro-opiomelanocortin (POMC) deficiency obesity due to rare bi-allelic loss-of function POMC or PCSK1 genetic mutations.
This research project will provide insight into the efficacy and safety of aspiration therapy in the management of obesity and its comorbidities in the Asian population, and will determine if there is a role for this novel...
This is a prospective, randomized clinical trial for patients with recurrent type 2 diabetes post-gastric bypass surgery that will compare a 6 month course of canagliflozin monotherapy vs. placebo on clinical outcomes of type 2 diabetes.
The purpose of this study is to determine the efficacy of of gastric bypass without gastric division as a treatment for morbid obesity.
American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.
Development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and the American College of Endocrinology...
This guideline makes recommendations on behaviours that may help people maintain a healthy weight or prevent excess weight gain. The...
This guideline updates and replaces section 1.2 in 'Obesity' (NICE clinical guideline 43: Obesity - Guidance on the prevention of...